drugset / Trial / NCT01014572
The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart
Phase 2
Completed
62 enrolled
University of Texas Southwestern Medical Center
National Institute on Aging (NIA) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether an investigational drug (Alagebrium (generic: ALT-711), a type of medication referred to as an advanced glycaton end-product clever) can be combined with exercise training to reverse the stiffening of the heart that takes place naturally with aging.
Timeline
- Start
- 2008-07
- Primary completion
- 2012-06
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | alagebrium | Small molecule | 100 mg | Oral |